Literature DB >> 21063918

Chronic migraine: epidemiology and disease burden.

Aubrey N Manack1, Dawn C Buse, Richard B Lipton.   

Abstract

Chronic migraine is a common and disabling complication of migraine with a population prevalence of about 2%. Emerging evidence suggests that episodic migraine and chronic migraine differ not only in degree, but also in kind. Compared with patients with episodic migraine, those with chronic migraine have worse socioeconomic status, reduced health-related quality of life, increased headache-related burden (including impairment in occupational, social, and family functioning), and greater psychiatric and medical comorbidities. Each year, approximately 2.5% of patients with episodic migraine develop new-onset chronic migraine (ie, chronification). Understanding the natural disease course, improving treatment and management, and preventing the onset could reduce the enormous individual and societal burden of chronic migraine, and thus, have become important goals of headache research. This review provides a summary of the history of nomenclature and diagnostic criteria, as well as recent studies focusing on the epidemiology, natural history, and burden of chronic migraine.

Entities:  

Mesh:

Year:  2011        PMID: 21063918     DOI: 10.1007/s11916-010-0157-z

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  44 in total

1.  Chronic daily headache: is analgesic overuse a cause or a consequence?

Authors:  Richard B Lipton; Marcelo E Bigal
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

2.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

Review 3.  Chronically evolving headaches: classification and terminology.

Authors:  G C Manzoni; G Lambru; P Torelli
Journal:  Neurol Sci       Date:  2006-05       Impact factor: 3.307

4.  Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors.

Authors:  S R Lu; J L Fuh; W T Chen; K D Juang; S J Wang
Journal:  Cephalalgia       Date:  2001-12       Impact factor: 6.292

5.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

Review 6.  Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability.

Authors:  W F Stewart; R B Lipton; A J Dowson; J Sawyer
Journal:  Neurology       Date:  2001       Impact factor: 9.910

7.  Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.

Authors:  P Zeeberg; J Olesen; R Jensen
Journal:  Cephalalgia       Date:  2008-09-24       Impact factor: 6.292

8.  The course of frequent episodic migraine in a large headache clinic population: a 12-year retrospective follow-up study.

Authors:  Carl G H Dahlöf; Maria Johansson; Susanne Casserstedt; Tina Motallebzadeh
Journal:  Headache       Date:  2009-09       Impact factor: 5.887

9.  Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

Authors:  Marcelo E Bigal; Daniel Serrano; Michael Reed; Richard B Lipton
Journal:  Neurology       Date:  2008-08-19       Impact factor: 9.910

10.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

View more
  73 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

2.  Migraine in men: fact sheet. A publication to mark European Migraine Day of Action 2014.

Authors:  Paolo Rossi; Giuseppe Nappi
Journal:  Funct Neurol       Date:  2014 Jul-Sep

3.  Onabotulinumtoxin A for chronic migraine with medication overuse: clinical results of a long-term treatment.

Authors:  Licia Grazzi
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 4.  Non-Invasive Neuromodulation for Headache Disorders.

Authors:  Shuhan Zhu; Michael J Marmura
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

Review 5.  Are Episodic and Chronic Migraine One Disease or Two?

Authors:  Reuben Burshtein; Aaron Burshtein; Joshua Burshtein; Noah Rosen
Journal:  Curr Pain Headache Rep       Date:  2015-12

Review 6.  [Treatment of chronic migraine with botulinum neurotoxin A : Expert recommendations of the German Migraine and Headache Society].

Authors:  R Ruscheweyh; S Förderreuther; C Gaul; A Gendolla; D Holle-Lee; T Jürgens; L Neeb; A Straube
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

7.  Spatial Heterogeneity of Cortical Excitability in Migraine Revealed by Multifrequency Neuromagnetic Signals.

Authors:  Jing Xiang; Kimberly Leiken; Xinyao Degrauw; Benjamin Kay; Hisako Fujiwara; Douglas F Rose; Janelle R Allen; Joanne E Kacperski; Hope L O'Brien; Marielle A Kabbouche; Scott W Powers; Andrew D Hershey
Journal:  J Pain       Date:  2016-03-10       Impact factor: 5.820

8.  Monoclonal antibodies for migraine prevention: hope, hype, and health economy challenge.

Authors:  David Kernick
Journal:  Br J Gen Pract       Date:  2020-07-30       Impact factor: 5.386

Review 9.  Economic burden and costs of chronic migraine.

Authors:  Michel Lanteri-Minet
Journal:  Curr Pain Headache Rep       Date:  2014-01

Review 10.  Emerging therapies for chronic migraine.

Authors:  Alberto Proietti Cecchini; Licia Grazzi
Journal:  Curr Pain Headache Rep       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.